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Abstract 
Phosphatidylinositol (PI) 3-kinase is composed of 110 kDa catalytic and 85 kDa regulatory subunits. The 110 kDa subunit has two 
intrinsic kinase activities, i.e., MnZ+-dependent protein-serine kinase and MgZ+-dependent lipid kinase activities. These intrinsic kinases 
have been reported to be interdependent: protein-serine kinase phosphorylates the 85 kDa subunit of PI 3-kinase, which upon 
phosphorylation i hibits the lipid kinase activity of PI 3-kinase. We report here that phosphoinositides can selectively inhibit the 
protein-serine kinase activity of PI 3-kinase without affecting lipid kinase activity. This inhibition depends on the phosphorylation status 
of the phosphoinositides, i.e., PI 4,5-bisphosphate > PI 4-phosphate >> PI. Mn 2+ (2 mM) protected protein kinase activity from 
phosphoinositides-mediated inhibition if added prior to interaction of PI 3-kinase with phosphoinositides. On the other hand, Mn 2+ (2 
mM) inhibited lipid kinase activity independent of its effect on the protein kinase activity of PI 3-kinase. The present study suggests that 
the protein-serine kinase and t)ae lipid kinase activities of PI 3-kinase can be selectively inhibited by phosphoinositides and Mn 2+ 
respectively. 
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1. Introduction 
Phosphoinositides (phosphatidylinositol, PI; PI 4-phos- 
phate, PIP; PI 4,5-bisphosphate, PIP 2) are minor but im- 
portant components of cell. PIP e, in particular, plays an 
important role in signal transduction: (1) it generates two 
intracellular second messengers upon receptor-mediated 
hydrolysis by phospholipase C, i.e., diacylglycerol (DG), 
an activator of protein kinase C (PKC) [1]; and inositol 
1,4,5-trisphosphate (IP3), a calcium mobilizer [2], (2) PIP 2 
is a potent PKC-activator in presence of Ca 2+ and 
phosphatidylserine (PS) [3-7], and (3) PIP 2 participates in 
the receptor-coupled actin polymerization by binding to 
the actin-binding or -capping proteins [8,9]. Another class 
of phosphoinositides, i.e., D-3 phosphorylated phospho- 
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inositides (PI 3-phosphate, PI 3-P; PI 3,4-bisphosphate, PI 
3,4-Pz; PI 3,4,5-trisphosphate, PIP 3) has been discovered 
in growth factor-stimulated cells [10]. These lipids are 
produced by the action of PI 3-kinase that phosphorylates 
phosphoinositides at 3 position of the inositol ring. PI 
3-kinase has emerged as an important signal transducing 
molecule in insulin, growth factors, and other agonists- 
mediated cellular signals [11]. It exists as heterodimer 
composed of regulatory 85 kDa and catalytic 110 kDa 
subunits [12,13]. In the agonist-stimulated cells, activation 
of tyrosine kinase activity of receptor leads to phospho- 
rylation at tyrosine residues of the 85 kDa subunit of PI 
3-kinase [14]. Phosphorylation and dephosphorylation of
PI 3-kinase at tyrosine residues results in activation and 
deactivation of this enzyme [15]. In addition to the phos- 
phorylation at tyrosine residues, PI 3-kinase can also get 
phosphorylated at serine residues. Many reports have indi- 
cated that PI 3-kinase copurifies with an associated pro- 
tein-serine kinase activity [16,17]. Recently, Dhand et al. 
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[l 8] reported that the protein-serine kinase activity is actu- 
ally intrinsic to its 110 kDa subunit with substrate speci- 
ficity for 85 kDa subunit of PI 3-kinase. This 85 subunit 
upon phosphorylation i  turn regulates phosphoinositide 
(lipid) kinase activity of PI 3-kinase, that is also intrinsic 
to the 110 kDa subunit. The authors also suggested that 
both serine- and lipid-kinase activities on 110 kDa subunit 
are catalyzed by single site that plays dual substrate speci- 
ficity [ 18]. 
We [19,20] and others [21-23] have reported that the 
activities of protein kinases such as protein kinase C 
(PKC), casein kinase I (CK I) and protein tyrosine kinase 
are inhibited by the direct interaction of these kinases with 
PIP 2 in the absence of divalent cations. We report here that 
the interaction of phosphoinositides with PI 3-kinase in the 
absence of divalent cations also inhibits its intrinsic protein 
kinase activity without affecting lipid kinase activity. 
Mn 2+, on the other hand, inhibits lipid kinase activity 
independent of its effect on protein kinase activity of PI 
3-kinase. These results suggest that two intrinsic activities 
of PI 3-kinase, i.e., protein serine kinase and lipid kinase 
can be independently regulated by phosphoinositides and 
Mn e + respectively. 
2.4. Lipid-kinase assay 
Activity of PI 3-kinase was measured by the method of 
Carpenter et al. [12] as described previously [24]. Assay 
mixture (25 /el) contained 2 mM MgCI2; 50 /xM [y_32p] 
ATP; 0.25 mM EDTA; 20 mM Tris-HCl (pH 7.2); 200 
/zM liposomes of individual phosphoinositides or phospho- 
inositides/PS (1:1, mol/mol). The reaction was started 
with PI 3-kinase, and stopped by the addition of 105/xl of 
1 N HCI, followed by 160 /xl of chloroform/methanol 
(1:1). Samples were vortexed vigorously, and centrifuged 
to separate aqueous and organic phase. The organic phase 
(30 /xl) was then transferred into scintillation vial, dried, 
and counted for radioactive phosphoinositides. 
2.5. Separation of PIP 3 
Separation of PIP 3 was done by TLC using 1% oxalated 
silica plates and solvent system of 2-propanol: 2 M acetic 
acid (65:35, V/V). PI, PIP, PIP 2 were used as standard 
markers, and visualized by iodine vapors. PIP 3 which 
always ran behind PIP 2 was identified by autoradiography. 
PIP 3 was also characterized by deacylation [25] and deg- 
lyceration [26]. 
2. Materials and methods 
2.1. Materials 
Phenylsepharose 4B, Mono Q, Mono S and Sephacryl 
S-200 were purchased from Pharmacia. [y-32 p] ATP (3000 
Ci/mmol) was purchased from New England Nuclear, and 
Ecoscint A from National Diagnostics. Anti PI 3-kinase 
(polyclonal) raised against 85 kDa subunit of PI 3-kinase 
was purchased from Upstate Biotechnology, New York. 
Bovine brain lipids (PS, PI, PIP and PIP e) and protein 
A-Sepharose were from Sigma. The purity of lipids was 
checked by thin layer chromatography (TLC). All other 
chemicals were from Sigma. 
2.2. Purification of PI 3-kinase 
The enzyme was partially purified from rat livers by the 
method of Carpenter et al. [12]. In brief, rat liver cytosol 
was subjected to acid precipitation followed by chromatog- 
raphy on DEAE-Sepharose, S-Sepharose, Mono Q and 
Mono S. 
2.3. Preparation of liposomes 
Organic solvent from the lipids PI, PIP or PIP 2, and 
phosphoinositides/PS (1:1, mol/mol) was evaporated un- 
der argon. Liposomes were prepared by suspending lipid 
film in 20 mM Tris-HCl containing 1mM EDTA (pH 7.2), 
followed by sonication under argon to clearing. 
2.6. Protein-serine kinase assay 
Reaction mixture (25 /el) contained PI 3-kinase, 40 mM 
triethanolamine (pH 7.6) containing 1 mM dithiothreitol 
(DTT), 10 mM Mn 2+ and 25 /zM [y_32p] ATP (0.6 
mCi//xmol ATP). Reaction was started with P! 3-kinase at 
37 ° C, and terminated after 30 min by the addition of 
sodium dodecylsulfate (SDS) stop solution (i.e., 20% (v/v) 
glycerol/10% (w/v) SDS, 10% (v/v) 2-mercapto- 
ethanol/0.25 M Tris-HC1 [pH 6.7]), and heating in a 
boiling water bath for 2 rain. The proteins were separated 
by SDS-slab gel electrophoresis (12%) and the labelled 
phosphoproteins detected by autoradiography. 
2.7. Immunoprecipitation of PI 3-kinase 
Partially purified PI 3-kinase (using DEAE-sepharose, 
S-sepharose and Mono Q column chromatography) was 
incubated overnight in 40 mM triethanolamine (pH 7.6), 
containing 0.2 M NaC1 and 1 mM DTT at 4 ° C with 3 /xl 
of polyclonal antisera raised against PI 3-kinase, followed 
by incubation for another 2 h with 60 /xl of protein A 
sepharose (1:1 slurry in 10 mM phosphate-buffered saline 
[pH 7.4]). After centrifugation, immunoprecipitates were 
washed three times with 10 mM phosphate-buffered saline 
(PBS) (pH 7.4) containing 0.1% NP-40, then washed twice 
with 1 mM Tris-HC1 (pH 7.5), containing 5 M LiC1, and 
twice with TNE buffer (10 mM Tris-HCl [pH 7.5], 100 
mM NaC1, 1 mM EDTA). This immunoprecipitated PI 
3-kinase was used for some experiments where indicated. 
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3. Results 
3.1. Inhibition of protein..serine kinase activity of PI 3- 
kinase by phosphoinositides 
We have shown earlier that preincubation of phospho- 
inositides with PKC [20] or CK I [19] in the absence of 
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Fig. 2. Concentration-dependent inhibition of protein-serine kinase activ- 
ity of PI 3-kinase by PIP2: PI 3-kinase was partially purified by DEAE 
sepharose, S-sepharose, Mono Q and Mono S column chromatography. 
This enzyme was preincubated with various concentrations of PIP 2, and 
protein-serine kinase activity measured. Radioactive labelled phosphopro- 
teins were visualized by autoradiography: lane 1, no PIP2; lane 2, 1 /zM 
PIP2; lane 3, 100 /xM PIP2; and lane 4, 200 /zM PI~. 
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Fig. 1. Inhibition of protein-serine kinase activity of PI 3-kinase by 
phosphoinositides: PI 3-kinase was partially purified from rat liver by the 
method of Carpenter et al. [12] by DEAE-sepharose, S-sepharose and 
Mono Q column chromatography. The enzyme was preincubated for 5 
min in the absence of phosphoinositides (lane 1) or with 200 /xM 
phosphoinositides, i.e., PI (lane 2), PIP (lane 3) or PIP 2 (lane 4), and 
protein-serine kinase activity measured in presence of Mn 2+ as described 
in Section 2 (A). In (B), PI 3-kinase was immunoprecipitated with 
antibodies to its 85 kDa subunit as described in Section 2. The immuno- 
precipitated enzyme was then preincubated with either 200 /xM PIP 2 
(lane 2), 200/~M PIP (lane 3) or 200/xM PI (lane 4), and protein-serine 
kinase activity was measured. Control, i.e., enzyme incubated in the 
absence of phospboinositides, is represented in lane 1. 
divalent cations results in the inhibition of the activities of 
these protein kinases. Here, we studied the effect of prein- 
cubation of PI 3-kinase with phosphoinositides in the 
absence of divalent cations on its intrinsic serine kinase 
activity. Mn 2+ was added to the reaction mixture after the 
interaction of PIP 2 with PI 3-kinase had taken place. 
Among the phosphoinositides studied, PIP e was the most 
effective in the inhibition of protein kinase activity of PI 
3-kinase; the order of inhibition was PIP: > PIP >> PI (Fig. 
1A). These experiments were done with partially purified 
PI 3-kinase. The results were then confirmed using im- 
munoprecipitated PI 3-kinase (Fig. 1B). In this experiment 
also, PIP inhibited serine kinase activity partially, while 
PIP 2 inhibited the protein phosphorylation activity com- 
pletely. Further experiments howed that inhibition of 
protein-serine kinase activity of PI 3-kinase by PIP 2 was 
dependent on PIP 2 concentration (Fig. 2). 
Molecular weight determinations u ing standard protein 
markers howed that the major phosphorylated protein was 
of 85 kDa molecular weight. In order to (a) confirm that PI 
3-kinase itself phosphorylates it 85 kDa subunit, as shown 
by Dhand et al. [18], and (b) rule out the possibility of 
phosphorylation of 85 kDa subunit of PI 3-kinase due to 
any contamination with other protein kinases, we studied 
the effect of wortmannin on protein phosphorylating activ- 
ity of the immunoprecipitated PI 3-kinase. Wortmannin is 
a specific inhibitor of protein- and lipid-kinase activities of 
PI 3-kinase [27]. We observed that 100 nM wortmannin 
completely inhibited the phosphorylation of the 85 kDa 
subunit of PI 3-kinase (data not shown). This finding 
suggests that phosphorylation f the 85 kDa subunit of PI 
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Fig. 3. Protection of PIP2-mediated inactivation of protein-serine kinase 
activity of PI 3-kinase by Mn2+: PI 3-kinase was preincubated with 200 
~M PIP 2 (lane 1), 200 /xM PIP2/PS (1:1) (lane 2) or 200 /xM PIP2/2 
mM Mn 2+ (lane 4) for 5 min at room temperature, and protein-serine 
kinase activity of the enzyme was measured. Controls were run with 
enzyme preincubated in the absence of lipids (lane 3). 
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Fig. 4. Effect of preincubation of PI 3-kinase with PIP 2 on lipid kinase 
activity: PI 3-kinase was preincubated with 200 /xM PIP 2 (lane 1) or 200 
/.LM PIP 2 /2  mM Mg 2+ (lane 2) for 5 min at room temperature, and lipid 
kinase activity measured after adjusting Mg 2+ final concentration to 2 
mM as described in Section 2. Separation of PIP 3 was done by TLC using 
1% oxalated silica G 60 plates, and 2-propanol:2M acetic acid (65:35, 
V /V)  as solvent system. PIP 3 was identified by autoradiography. 
Fig. 5. Inhibition of lipid kinase activity of PI 3-kinase by Mn2+: PI 
3-kinase was partially purified from rat liver by the method of Carpenter 
et al. [12]. Mg2+-dependent lipid kinase activity was measured in the 
presence of various concentrations of Mn 2+ (0-4 mM) (A). Assay 
mixture (25 /xl) contained 2 mM MgCI 2, PI 3-kinase, 50 /xM (T-32p) 
ATP, 0.25 mM EDTA, 20 mM Tris-HCl (pH 7.2), 200 /xM PIP 2 /PS 
(1:1) liposomes and Mn 2+ (0-4 mM). The reaction was started with PI 
3-kinase at 37 ° C, and stopped by the addition of 105/zl of 1 N HC1 after 
10 min. Lipids were extracted after adding 160/zl of chloroform:methanol 
(1 : 1, V/V). 30/xl of organic phase containing radioactive PIP 3 was dried 
in a scintillation vial and counted in 5 ml of Ecoscint A. In (B), 
protein-serine kinase activity of PI 3-kinase was inhibited by prior 
incubation of enzyme with 200 /xM PIP 2 for 5 min at room temperature, 
and lipid kinase activity measured in the absence, i.e., control (lane 2) 
and presence of 2 mM Mn 2+ (lane 3). In lane 1, PI 3-kinase was 
incubated for 5 rain in the absence of PIP 2, and lipid kinase activity 
measured in the presence of 2 mM Mn 2+. 
3 -k inase  was  due  to the  intr ins ic  prote in  k inase  act iv i ty  o f  
the  enzyme.  
3.2. Effect of Mn 2+ on the interaction of PIP 2 with 
protein-serine kinase actiuity of PI 3-kinase 
When Mn ~-+ was  added to the react ion  af ter  P IP2 /P I  
3 -k inase  in teract ion  in above  exper iments  (Fig.  IA ,B) ,  
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PIP 2 inhibited protein-serine kinase activity of PI 3-kinase. 
On the other hand, the addition of Mn 2+ prior to PIP 2 
interaction with PI 3-kinase protected the protein-serine 
kinase activity from inhibition by phosphoinositides (Fig. 
3). These results suggest that PIP 2 induces irreversible 
changes in PI 3-kinase which cannot be overcome by 
Mn 2+ if added after the lipid/protein interaction has taken 
place. 
3.3. Effect of preincubation of Pl 3-kinase with PIP 2 on its 
lipid kinase activity 
In order to investigate if preincubation of PI 3-kinase 
with PIP 2 also affects its lipid kinase activity, PIP 2 and PI 
3-kinase were incubated for 5 minutes, then PI 3-kinase- 
mediated PIP 2 phosphorylation was assayed. We observed 
that prior incubation of PI 3-kinase with PIP 2 (200/zM) in 
absence or presence of Mg 2+ (2 mM) did not affect the 
phosphorylation of lipids as depicted from autoradiogram 
(Fig. 4) and lipid-kinase activity (assayed by counting for 
radioactive 32p in the organic phase after drying). It was 
10353 cpm and 8636 cpm when PI 3-kinase was preincu- 
bated with 200 /~M PIP 2 in the absence and presence of 2 
mM Mg 2+ respectively. 
3.4. Inhibition of lipid kinase acticity of PI 3-kinase by 
mn 2 + 
Dhand et al. [18] reported that protein-serine kinase 
activity of PI 3-kinase is MnZ+-dependent, while its lipid- 
kinase activity is Mg2+-dependent. We found that PI 
3-kinase-mediated phosphorylation f PIP 2 (assayed in the 
presence of 2 mM Mg 2 + ) was inhibited in a 
concentration-dependent manner by Mn 2+ (0.5-2 raM) 
with an ICs0 of 1.5 raM, and ~ 90% inhibition at 2 mM 
Mn 2+ (Fig. 5A). This inhibition of lipid kinase activity by 
Mn 2+ could be due to phosphorylation of the 85 kDa 
subunit of PI 3-kinase by its Mn2+-dependent serine kinase 
activity or due to the direct interaction of enzyme with 
Mn 2+. In order to investigate how Mn 2+ contributed to the 
inhibition of lipid kinase activity of PI 3-kinase, we inhib- 
ited protein-serine kinase .activity of PI 3-kinase by prior 
incubation of PI 3-kinase with 200 /zM PIP 2 (it should be 
noted that under this condition lipid kinase activity of PI 
3-kinase is not altered as shown in Fig. 4), and then 
studied the phosphorylation of PIP 2 in presence of 2 mM 
Mn 2+ and 2 mM Mg 2+ (Fig. 5B). The addition of 2 mM 
Mn 2+ was found to inhibit the lipid kinase activity, sug- 
gesting that Mn 2+ inhibits lipid kinase activity indepen- 
dent of phosphorylation of PI 3-kinase by protein-serine 
kinase. 
4. Discussion 
Several laboratories have observed that PI 3-kinase, a 
lipid-phosphorylating enzyme, is associated with protein- 
serine kinase activity [16,17]. Recently Dhand et al. [18] 
reported that the serine kinase activity is an intrinsic 
property of PI 3-kinase that is Mn2+-dependent. The lipid 
kinase activity of PI 3-kinase, on the other hand, is Mg 2+- 
dependent. They suggested that both the catalytic reactions 
are catalyzed by the same active site that is present on the 
110 kDa subunit of the enzyme. This conclusion was based 
on the observations that both the activities, i.e., lipid 
kinase and protein kinase, are inhibited by the single 
substitution of arginine 916 with proline; both activities 
co-sediment on sucrose gradient; require thiol groups, and 
are inactivated by 5,5'-dithio-bis [2-nitrobenzoic acid] 
(NbS2) while reactivated by dithiothreitol (DTT). 
We report here that these two intrinsic kinase activities 
of PI 3-kinase can be regulated independently by phospho- 
inositides and Mn 2+. The prior incubation of P1 3-kinase 
with phosphoinositides in the absence of any divalent 
cation inhibits only protein serine kinase activity without 
affecting the lipid kinase activity; and Mn 2+ inhibits lipid 
kinase activity independent of its effect on protein-serine 
kinase activity. The inhibition of protein serine kinase was 
found to be dependent on the degree of phosphorylation f 
phosphoinositides, i.e., PIP 2 inhibited the serine kinase 
completely while PIP inhibited slightly, and no inhibition 
was observed with PI. 
We [19] and others [21-23] have reported that preincu- 
bation of other protein kinases such as CK I, PKC and 
protein tyrosine kinase (PTK) with PIP 2 inhibits the pro- 
tein phosphorylation by these kinases. The PIPz-mediated 
inhibition of PKC was due to irreversible conformational 
changes induced in the enzyme [20]. It has been reported 
that phosphorylation f the 85 kDa subunit of PI 3-kinase 
by its intrinsic MnZ+-dependent protein-serine kinase ac- 
tivity results in the inhibition of its lipid kinase activity 
[18]. We suggest hat phosphoinositides-mediated inhibi- 
tion of intrinsic protein-serine kinase of PI 3-kinase in the 
absence of divalent cation in the present study may also be 
due to irreversible conformational change induced in the 
85 kDa subunit of PI 3-kinase as a result of binding to 
phosphoinositides, that will prevent its binding to a pro- 
tein-serine kinase catalytic site and thus its phosphoryla- 
tion. This hypothesis i supported by the recent report [28] 
that inter-SH2 domain of the 85 kDa subunit of PI 3-kinase 
contains lipid binding domain which binds preferentially to
phosphoinositides in the order PIP2 > PIP > PI. 
In our previous reports [19,20], we suggested that inhi- 
bition of protein kinases, i.e., PKC and CK I after preincu- 
bation with phosphoinositides is due to enzyme/lipid in- 
teraction and not due to interaction of lipids with the 
substrates because substrates were added in the reaction 
after the enzyme/lipid interaction had taken place. In the 
case of PI 3-kinase, substrate (the 85 kDa subunit) and 
catalytic subunit (110 kDa) were present at the time of 
lipid/protein interaction. Thus direct interaction of the 85 
kDa substrate with phosphoinositides can cause the inhibi- 
tion of protein-serine kinase activity of PI 3-kinase. 
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We have argued earlier that the inhibition of protein 
kinases by phosphoinositides may not have any physio- 
logical significance because the inhibition of protein ki- 
nases is not observed if divalent cations [19] or polyvalent 
cations [20] are present before the enzyme/lipid interac- 
tions. In this study also, protein-kinase activity was not 
inhibited by PIP 2 when Mn 2÷ was present before the 
PIP2/PI 3-kinase interaction. However, PI 3-kinase is 
different from other protein-phosphorylating e zymes; it 
contains lipid-binding domain in its regulatory 85 kDa unit 
[28]. We suggest hat the lipid-binding domain of the 85 
kDa subunit may have a physiological role. It may be 
involved in forming a specific substrate pocket where 
phosphoinositides especially PIP 2 can bind efficiently. This 
protein-lipid binding may then facilitate the phosphoryla- 
tion of phosphoinositides by inhibiting the serine-kinase 
activity of PI 3-kinase. The selective inhibition of protein- 
kinase activity by PIP 2 (and no inhibition by PI) without 
affecting lipid kinase activity and of lipid kinase activity 
by Mn 2+ suggest that these two activities can be indepen- 
dently regulated and may be catalyzed by different sites. 
One cannot exclude the possibility that these two indepen- 
dent catalytic sites may be overlapping or the smaller one 
may be contained entirely within the other in the same 
catalytic region. The implication from the elegant experi- 
ments of Dhand et al. [18] that both lipid kinase and 
protein kinase activity are catalyzed by the single site has 
room for different interpretation. In their experiments, 
changing R916P at the catalytic site may result in the 
conformational change of the enzyme in a way that both 
catalytic activities are inhibited. Also, the inactivation of 
both activities by NbS2 and reactivation by DTT is also 
possible if both the activities, if catalyzed by independent 
sites, require sulfhydryl groups. Furthermore, it is highly 
unlikely that a single catalytic site, as suggested by Dhand 
et al. [18], will phosphorylate hydroxyl groups of amino 
acid in protein and phosphoinositides, two vastly different 
molecules. 
We report here that Mn 2+ inhibits the lipid kinase 
activity of PI 3-kinase independent of protein-serine phos- 
phorylation of the enzyme. In those experiments where 
protein-serine kinase activity was inhibited by 200 /xM 
PIP 2, the addition of 2 mM Mn 2÷ in presence of 2 mM 
Mg2+ inhibited the lipid kinase activity in a 
concentration-dependent manner (Figs. 1 and 2). It should 
be mentioned here that Mn 2÷ is a cofactor for protein 
kinase activity, but it inhibits lipid kinase activity indepen- 
dent of protein phosphorylation. 
In conclusion, selective inhibition of intrinsic serine 
kinase activity of PI 3-kinase by PIP 2, and inhibition of its 
lipid kinase activity by Mn 2÷ suggest hat two catalytic 
properties involving phosphorylation f very different sub- 
strates, i.e., lipid and protein, may be present at different 
overlapping sites, and that these two activities can be 
regulated independently of each other. 
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